Press Releases

Featured Press Releases

BIO Elects Genentech’s Fritz Bittenbender as New…

Industry veteran takes the helm as Dr. Ted Love concludes two-year term marked by strategic growth and transition BOSTON (June 16, 2025) – Today, the Biotechnology Innovation Organization (BIO) announced that Fritz Bittenbender,…

Learn more

BIO International Convention Opens in Boston,…

The world’s largest biotech gathering unites 20,000+ leaders to accelerate breakthroughs that heal, protect, and nourish humanityBOSTON (June 16, 2025) The BIO International Convention, the world’s largest and most comprehensive event for…

Learn more

BIO Statement on HHS Dismissal of CDC Advisory…

WASHINGTON, D.C. - John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement regarding today’s dismissal of the voting members of the CDC Advisory Committee on Immunization Practices: …

Learn more

New Direction for Communications and Public Affairs for BIO

June 3, 2019

BIO announces the hiring of Rich Masters as BIO's new Executive Vice President (EVP) for Public Affairs. Rich officially will join BIO on June 17th.

Year-Round Use of 15 Percent Biofuels in Gasoline Will Reduce Pollution and Save Americans Billions of Dollars

May 31, 2019

The Biotechnology Innovation Organization (BIO) today released the following statement after the U.S. Environmental Protection Agency (EPA) finalized its rule allowing for the year-round use E15 gasoline.

BIO Releases 5th Annual Emerging Therapeutic Company Trend Report Showing Record Year for Venture Capital Funding

May 31, 2019

Washington, D.C. (May 31, 2019) – Today, the Biotechnology Innovation Organization (BIO) released the 2019 Emerging Therapeutic Company Trend Report, highlighting ten years (2009-2018) of biotechnology funding and deal making across five areas:…

BIO Honors Dr. Emil D. Kakkis with 2019 Henri A. Termeer Biotechnology Visionary Award

May 29, 2019

BIO announces the winner of this year’s Henri A. Termeer Biotechnology Visionary Award: Emil D. Kakkis, MD, PhD, President and Chief Executive Officer, Ultragenyx (NASDAQ: RARE) and Founder, EveryLife Foundation for Rare Diseases. The award,…

Former U.S. Secretary of Agriculture and Iowa Governor to Receive 2019 George Washington Carver Award

May 20, 2019

The Biotechnology Innovation Organization (BIO) today announced that former U.S. Department of Agriculture (USDA) Secretary and former two-term Governor of Iowa Tom Vilsack will receive the 12th annual George Washington Carver Award for Innovation…

BIO Applauds Senate Passage of the Pandemic and All-Hazards Preparedness and Advancing Innovation Act

May 17, 2019

Washington, DC (May 17, 2019) – The Biotechnology Innovation Organization (BIO) today applauds the Senate passage of the Pandemic and All-Hazards Preparedness and Advancing Innovation (PAHPAI) Act (S. 1379). The legislation would re-authorize…

New BIO Report: More Progress Needed in Innovation of Alzheimer’s Disease Therapeutics

May 14, 2019

Today, the Biotechnology Innovation Organization (BIO) released a new report, The State of Innovation in Highly Prevalent Chronic Diseases Volume IV: Alzheimer’s Disease Therapeutics, the fourth in a series on the innovation landscape of highly…

BIO Continues Partnership with NIH for Fifth “Innovation Zone” Exhibit

May 8, 2019

Washington, D.C. (May 8, 2019) – The Biotechnology Innovation Organization (BIO) and the National Institutes of Health (NIH) today announced an agreement to feature Small Business Innovation Research (SBIR)-funded early-stage biomedical companies in…

Congress to EPA: Stop Undercutting Family Farms and Our Nation’s Renewable Fuel Future

May 7, 2019

Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood today expressed support for a U.S. House of Representatives letter, authored by Representatives Cindy Axne (D-Iowa) and Adrian Smith (R-Neb.), requesting U.S. Environmental…

Influential CEO Jamie Dimon to Deliver Keynote at BIO 2019

April 29, 2019

The Biotechnology Innovation Organization (BIO) today announced that Chairman and CEO of JPMorgan Chase & Co., Jamie Dimon – a leader in the banking industry and catalyst for innovation across American business, including the healthcare industry…

Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.